Toshio Kanno

Toshio Kanno

Auto-generated profile, based on publicly available information

Toshio Kanno

Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
TNTakahiro Nakajima
Takahiro Nakajima
TKToshio Kanno
Toshio Kanno
SYSatoru Yokoyama
Satoru Yokoyama
SSShigemi Sasamoto
Shigemi Sasamoto
HAHikari K. Asou
Hikari K. Asou
YEYusuke Endo
Yusuke Endo
T cells possess distinguishing effector functions and drive inflammatory disorders. We have previously identified IL-5–producing Th2 cells as the pathogenic population predominantly involved in the pathology of allergic inflammation. However, the cell-intrinsic signaling pathways that control the pathogenic Th2 cell function are still unclear. We herein report the high expression of acetyl-CoA carboxylase 1 (ACC1) in the pathogenic CD4+ T cell population in the lung and skin. The genetic deletion of CD4+ T cell–intrinsic ACC1 dampened eosinophilic and basophilic inflammation in the lung and skin by constraining IL-5 or IL-3 production. Mechanistically, ACC1-dependent fatty acid biosynthesis induces the pathogenic cytokine production of CD4+ T cells via metabolic reprogramming and the availability of acetyl-CoA for epigenetic regulation. We thus identified a distinct phenotype of the pathogenic T cell population in the lung and skin, and ACC1 was shown to be an essential regulator controlling the pathogenic function of these populations to promote type 2 inflammation.

4 August 2023 in Science Immunology
Verified
Journal Article
Closed access
YEYusuke Endo
Yusuke Endo
TKToshio Kanno
Toshio Kanno
TNTakahiro Nakajima
Takahiro Nakajima
KIKazutaka Ikeda
Kazutaka Ikeda
YTYoshitaka Taketomi
Yoshitaka Taketomi
TNToshinori Nakayama
Toshinori Nakayama
Metabolic fluxes involving fatty acid biosynthesis play essential roles in controlling the differentiation of T helper 17 (T H 17) cells. However, the exact enzymes and lipid metabolites involved, as well as their link to promoting the core gene transcriptional signature required for the differentiation of T H 17 cells, remain largely unknown. From a pooled CRISPR-based screen and unbiased lipidomics analyses, we identified that 1-oleoyl-lysophosphatidylethanolamine could act as a lipid modulator of retinoid-related orphan receptor gamma t (RORγt) activity in T H 17 cells. In addition, we specified five enzymes, including Gpam , Gpat3 , Lplat1 , Pla2g12a , and Scd2 , suggestive of the requirement of glycerophospholipids with monounsaturated fatty acids being required for the transcription of Il17a . 1-Oleoyl-lysophosphatidylethanolamine was reduced in Pla2g12a -deficient T H 17 cells, leading to the abolition of interleukin-17 (IL-17) production and disruption to the core transcriptional program required for the differentiation of T H 17 cells. Furthermore, mice with T cell–specific deficiency of Pla2g12a failed to develop disease in an experimental autoimmune encephalomyelitis model of multiple sclerosis. Thus, our data indicate that 1-oleoyl-lysophosphatidylethanolamine is a lipid metabolite that promotes RORγt-induced T H 17 cell differentiation and the pathogenicity of T H 17 cells.

26 August 2024 in Cellular & Molecular Immunology
Verified
Journal Article
Open access
PDF file
TNTakahiro Nakajima
Takahiro Nakajima
TKToshio Kanno
Toshio Kanno
YUYuki Ueda
Yuki Ueda
KMKeisuke Miyako
Keisuke Miyako
TETakeru Endo
Takeru Endo
YEYusuke Endo
Yusuke Endo
T helper 9 (Th9) cells are interleukin 9 (IL-9)-producing cells that have diverse functions ranging from antitumor immune responses to allergic inflammation. Th9 cells differentiate from naïve CD4+ T cells in the presence of IL-4 and transforming growth factor-beta (TGF-β); however, our understanding of the molecular basis of their differentiation remains incomplete. Previously, we reported that the differentiation of another subset of TGF-β–driven T helper cells, Th17 cells, is highly dependent on de novo lipid biosynthesis. On the basis of these findings, we hypothesized that lipid metabolism may also be important for Th9 cell differentiation. We therefore investigated the differentiation and function of mouse and human Th9 cells in vitro under conditions of pharmacologically or genetically induced deficiency of the intracellular fatty acid content and in vivo in mice genetically deficient in acetyl-CoA carboxylase 1 (ACC1), an important enzyme for fatty acid biosynthesis. Both the inhibition of de novo fatty acid biosynthesis and the deprivation of environmental lipids augmented differentiation and IL-9 production in mouse and human Th9 cells. Mechanistic studies revealed that the increase in Th9 cell differentiation was mediated by the retinoic acid receptor and the TGF-β–SMAD signaling pathways. Upon adoptive transfer, ACC1-inhibited Th9 cells suppressed tumor growth in murine models of melanoma and adenocarcinoma. Together, our findings highlight a novel role of fatty acid metabolism in controlling the differentiation and in vivo functions of Th9 cells.

23 May 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
TKToshio Kanno
Toshio Kanno
RKRyo Konno
Ryo Konno
MSMasaru Sato
Masaru Sato
AKAtsushi Kurabayashi
Atsushi Kurabayashi
KMKeisuke Miyako
Keisuke Miyako
YEYusuke Endo
Yusuke Endo
Recent studies have highlighted the significance of cellular metabolism in the initiation of clonal expansion and effector differentiation of T cells. Upon exposure to antigens, naïve CD4+ T cells undergo metabolic reprogramming to meet their metabolic requirements. However, only few studies have simultaneously evaluated the changes in protein and metabolite levels during T cell differentiation. Our research seeks to fill the gap by conducting a comprehensive analysis of changes in levels of metabolites, including sugars, amino acids, intermediates of the TCA cycle, fatty acids, and lipids. By integrating metabolomics and proteomics data, we discovered that the quantity and composition of cellular lipids underwent significant changes in different effector Th cell subsets. Especially, we found that the sphingolipid biosynthesis pathway was commonly activated in Th1, Th2, Th17, and iTreg cells and that inhibition of this pathway led to the suppression of Th17 and iTreg cells differentiation. Additionally, we discovered that Th17 and iTreg cells enhance glycosphingolipid metabolism, and inhibition of this pathway also results in the suppression of Th17 and iTreg cell generation. These findings demonstrate that the utility of our combined metabolomics and proteomics analysis in furthering the understanding of metabolic transition during Th cell differentiation.

8 October 2024 in Cellular & Molecular Immunology
Verified
Journal Article
Open access
PDF file
TNTakahiro Nakajima
Takahiro Nakajima
TKToshio Kanno
Toshio Kanno
YUYuki Ueda
Yuki Ueda
KMKeisuke Miyako
Keisuke Miyako
TETakeru Endo
Takeru Endo
YEYusuke Endo
Yusuke Endo

14 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
DNDaisuke Nakajima
Daisuke Nakajima
TKToshio Kanno
Toshio Kanno
YOYusei Okuda
Yusei Okuda
HMHiromasa Mitsui
Hiromasa Mitsui
RKRyo Konno
Ryo Konno
YKYusuke Kawashima
Yusuke Kawashima
Dried blood spots (DBS) are well-established microsamples used in clinical testing and newborn screening. However, their use in deep proteomics is hindered by highly abundant blood proteins and inefficient protein recovery from filter paper matrices. The non-targeted analysis of non-specifically DBS-absorbed proteins (NANDA) workflow partially overcomes the impact of abundant blood proteins and has enabled the identification of over 5,000 proteins from DBS samples. Nonetheless, residual abundant proteins, including hemoglobin and fibrinogen, constrain deep proteomic analysis. Therefore, this study aimed to evaluate the effects of the metal chelator ethylenediaminetetraacetic acid (EDTA) on the depth of DBS proteomic analysis. An optimized EDTA-enhanced NANDA protocol that incorporated a 100 mM EDTA wash step was compatible with standard DBS collection procedures and required no modification of current clinical workflows, markedly enhancing the depletion of abundant proteins and facilitating its potential use in clinical and translational settings. When combined with Orbitrap Astral data-independent acquisition mass spectrometry, this approach enabled the single-shot identification of more than 7,000 proteins from DBS samples; to the best of our knowledge, this represents the deepest proteome coverage reported to date, and the workflow further supported high-throughput and highly reproducible analyses. Additionally, its application to mouse disease models revealed disease-specific systemic immune signatures from minimal blood volumes. Collectively, these results establish EDTA-enhanced NANDA as a practical and scalable workflow that overcomes longstanding limitations of DBS proteomics, thereby enabling deep, high-throughput, minimally invasive proteomic profiling across diverse biological and experimental contexts.